| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/17/2006 | US6986890 Anti-human VEGF receptor Flt-1 monoclonal antibody |
| 01/17/2006 | US6986889 Complexing; removal from blood circulation |
| 01/17/2006 | CA2374882C Molecular characterisation of chromosome translocation t(11;18)(q21;q21) and its correlation to carcinogenesis |
| 01/17/2006 | CA2271544C Method to detect bone and other connective tissue disorders in humans and animals |
| 01/12/2006 | WO2006004988A2 B7-dc binding antibody |
| 01/12/2006 | WO2006004950A2 Humanized monoclonal antibody 31.1 as an anticancer agent |
| 01/12/2006 | WO2006004910A2 Improved bispecific antibodies |
| 01/12/2006 | WO2006004878A1 Attenuated herpes simplex virus type-2, vectors thereof and immunogenic compositions thereof |
| 01/12/2006 | WO2006004749A2 Compositions and methods for treating neurological disorders |
| 01/12/2006 | WO2006004736A2 Stable liquid and lyophilized formulation of proteins |
| 01/12/2006 | WO2006004716A2 Amelioration of drug-induced toxicity |
| 01/12/2006 | WO2006004620A2 Enterotoxin gene cluster (egc) superantigens to treat malignant disease |
| 01/12/2006 | WO2006004593A2 Method for preventing and treating mast cell mediated diseases |
| 01/12/2006 | WO2006004588A2 Immunodynamic complexes and methods for using and preparing such complexes |
| 01/12/2006 | WO2006003518A2 6-phosphorylcholine-n-acetyl-d-galactosamine conjugate molecules and their use in vaccinal, therapeutic and diagnostic applications against bacterial infection of the respiratory tract |
| 01/12/2006 | WO2006003426A1 Treatment of bacterial infections |
| 01/12/2006 | WO2006003384A1 Treatment of cancer |
| 01/12/2006 | WO2006002889A2 Improved adjuvant therapy of g250-expressing tumors |
| 01/12/2006 | WO2006002774A1 Novel monoclonal thyroid stimulating or blocking antibodies, peptide sequences corresponding their variable regions, and their uses in diagnostic, preventive and therapeutic medicine |
| 01/12/2006 | WO2006002642A2 Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids |
| 01/12/2006 | WO2006002631A1 Method for multiple sclerosis treatment and prophylaxis by treatment of leptospira infection |
| 01/12/2006 | WO2006002502A1 Process for obtention of new cellular pertussis vaccine |
| 01/12/2006 | WO2005111080A3 Methods for reducing biofilm formation in infectious bacteria |
| 01/12/2006 | WO2005110472A8 Agent for actively restoring structure and functions of damaged tissues and organs |
| 01/12/2006 | WO2005094883A3 Methods for inducing autolysis in infectious bacteria |
| 01/12/2006 | WO2005090573A3 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 01/12/2006 | WO2005079479A3 Super-humanized antibodies against respiratory syncytial virus |
| 01/12/2006 | WO2005058362A3 Method for opening tight junctions comprising the use of jam-1, claudin-4 and occludin protein antagonists as well as sirna molecules |
| 01/12/2006 | WO2005046449A3 Soluble tcr molecules and methods of use |
| 01/12/2006 | WO2005030123A3 Botulinum antitoxin compositions and methods |
| 01/12/2006 | WO2005027836A3 Immunogen |
| 01/12/2006 | WO2005018574A3 Immunostimulatory combinations and treatments |
| 01/12/2006 | WO2005009335A3 Live attenuated nidovirus vaccines |
| 01/12/2006 | WO2004098529A3 Therapeutic compositions and vaccines by glycosyl-phosphatidylinositol (gpi)-anchored cytokines and immunostimulatory molecules |
| 01/12/2006 | WO2004078130A3 Posh interacting proteins and related methods |
| 01/12/2006 | WO2004062597A3 Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector |
| 01/12/2006 | WO2003089596A3 Novel prostate tumor-specific promoter |
| 01/12/2006 | WO2003084470A3 Compositions and methods for targeted biological delivery of molecular carriers |
| 01/12/2006 | US20060009622 inflammatory bowel disease, rheumatoid arthritis, acromegaly, tuberculosis, tumor of the lung, breast, brain, eye, prostate or colon, a tumor of neuroendocrine origin, an angiogenesis disease that causes inappropriate proliferation of blood vessels, retinal macular degeneration or diabetic neuropathy |
| 01/12/2006 | US20060009619 Polypeptide sequences related to ricin A chain but lack or have reduced detectable N-glycosidase-rRNA activity; treating or preventing ricin intoxication |
| 01/12/2006 | US20060009452 Therapeutic targeting of PARC/CCL18 and its signaling in pulmonary fibrosis |
| 01/12/2006 | US20060009444 Method for decreasing depression by inhibiting the activity of n-type calcium channel |
| 01/12/2006 | US20060009419 Therapy-enhancing glucan |
| 01/12/2006 | US20060009388 Treatment of conditions involving demyelination |
| 01/12/2006 | US20060009385 Multiple-variable dose regimen for treating TNFalpha-related disorders |
| 01/12/2006 | US20060009382 Use of a CD28 binding pharmaceutical substance for making a pharmaceutical composition with dose-dependent effect |
| 01/12/2006 | US20060009380 Isolated deoxyribonucleic acid fragment that codes for the calcium binding proteins; treating skin disorders, like dry skin, hyperkeratosis, parakeratosis, psoriasis, ichthyosis, and neoplasia; cosmetics |
| 01/12/2006 | US20060008889 Phosphatase specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative, autoimmune, muscular and graft vs. host diseases |
| 01/12/2006 | US20060008873 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 01/12/2006 | US20060008797 Peptide that that binds to microglial receptors; may be conjugated to a carrier molecule that increases transport across the blood-brain barrier; treating neurological effects of cerebral ischemia or cerebral inflammation |
| 01/12/2006 | US20060008532 Complexes of protein crystals and ionic polymers |
| 01/12/2006 | US20060008519 Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids |
| 01/12/2006 | US20060008479 Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins |
| 01/12/2006 | US20060008478 Immunoadjuvant |
| 01/12/2006 | US20060008477 Phenotype-determining virulence genes of pseudomonas aeruginosa for colonization and persistence in human beings, animals and plants, uses of said gene and associated proteins |
| 01/12/2006 | US20060008476 Adjuvanted antigenic meningococcal compositions |
| 01/12/2006 | US20060008475 Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to Gb3 expressing tumors |
| 01/12/2006 | US20060008474 Polypeptides containing polymorphisms of the repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions |
| 01/12/2006 | US20060008473 Influenza hemagglutinin and neuraminidase variants |
| 01/12/2006 | US20060008472 For therapy and prophylaxis of cancers and other infectious diseases |
| 01/12/2006 | US20060008471 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus |
| 01/12/2006 | US20060008470 Use of vaccinia virus deleted for the E3L gene as a vaccine vector |
| 01/12/2006 | US20060008469 Infectious clone of human parvovirus B19 and methods |
| 01/12/2006 | US20060008468 Combinations of tumor-associated antigens in diagnostics for various types of cancers |
| 01/12/2006 | US20060008467 Human immunodeficiency virus vaccine |
| 01/12/2006 | US20060008466 Methods for treating and preventing microbial infections |
| 01/12/2006 | US20060008465 Novel methods for therapeutic vaccination |
| 01/12/2006 | US20060008464 Histone conjugates and uses thereof |
| 01/12/2006 | US20060008463 Tumor antigen peptides derived from cyclophilin B |
| 01/12/2006 | US20060008462 Treatment of mammalian reaction of ige interactions |
| 01/12/2006 | US20060008461 Delivering into phagocytic cells; targeting specific organelles; inhibiting, attenuating, arresting, combating and overcoming microbial infection of phagocytic mammalian cells in vivo and in vitro |
| 01/12/2006 | US20060008460 Inhibits B-cell activation by binding to protein receptor on helper T-cell membrane; treatment of allergy or autoimmune disease |
| 01/12/2006 | US20060008459 Combination therapy of respiratory diseases using antibodies |
| 01/12/2006 | US20060008458 Prevention of brain inflammation as a result of induced autoimmune response |
| 01/12/2006 | US20060008457 Use of an active substance binding to CD28 for producing a pharmaceutical composition for the treatment of B-CLL |
| 01/12/2006 | US20060008456 Natural humanized antibody |
| 01/12/2006 | US20060008415 Stable liquid and lyophilized formulation of proteins |
| 01/12/2006 | DE102005007690A1 Medium, useful for increasing tumor resistance in organisms and for prophylaxis of oncological diseases, comprises rabies vaccine |
| 01/12/2006 | DE102004031116A1 Verfahren zum Auffinden schmerzrelevanter Substanzen unter Verwendung schmerzrelevanter Proteine A method for finding relevant substances pain using pain-relevant proteins |
| 01/12/2006 | CA2579779A1 Method for multiple sclerosis treatment and prophylaxis by treatment of leptospira infection |
| 01/12/2006 | CA2572985A1 Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids |
| 01/12/2006 | CA2572684A1 Amelioration of drug-induced toxicity |
| 01/12/2006 | CA2572321A1 Anti-synoviolin antibody |
| 01/12/2006 | CA2572318A1 Treatment of cancer |
| 01/12/2006 | CA2572133A1 Increasing the production of recombinant antibodies in mammalian cells by site-directed mutagenesis |
| 01/12/2006 | CA2571957A1 Methods and compositions using cd3 agonists |
| 01/12/2006 | CA2571536A1 Compositions and methods for treating inflammatory disorders |
| 01/12/2006 | CA2571035A1 Compositions and methods for treating neurological disorders |
| 01/12/2006 | CA2569983A1 Recombinant rsv strains with altered g protein |
| 01/12/2006 | CA2569557A1 Treatment of bacterial infections |
| 01/12/2006 | CA2568427A1 Method for preventing and treating mast cell mediated diseases |
| 01/12/2006 | CA2567758A1 Stable liquid and lyophilized formulation of proteins |
| 01/12/2006 | CA2566950A1 Improved adjuvant therapy of g250-expressing tumors |
| 01/11/2006 | EP1614695A1 Polypeptide |
| 01/11/2006 | EP1614427A1 Inactivated vibrio cholerae vaccine in tablet form |
| 01/11/2006 | EP1614426A1 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same |
| 01/11/2006 | EP1614425A2 Leukotriene receptor antagonist |
| 01/11/2006 | EP1614423A2 Attenuated pestiviruses |
| 01/11/2006 | EP1613757A2 Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes |
| 01/11/2006 | EP1613752A2 Chimaeric protein containing cysteine protease of liver fluke fused to hepatitis b core protein or ubiquitin, plants expressing said protein, and uses thereof as vaccine |